EUVIMEDEUVIMED entdecken
Crossref

Persistence of IgG and neutralizing antibodies in Crimean−Congo hemorrhagic fever survivors

Abbas Ahmadi Vasmehjani, Mohammad Hassan Pouriayevali, Shohreh Shahmahmoodi, Mostafa Salehi-Vaziri iD

Journal of Medical Virology · 2024

DOI: 10.1002/jmv.29581 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Abbas Ahmadi Vasmehjani und 3 weiteren Autor:innen. Beteiligte Einrichtung: Virology Department, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Hemorrhagic Fever, Crimean, Hemorrhagic Fever Virus, Crimean-Congo. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Tehran University of Medical Sciences and Health Services.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The World Health Organization classified Crimean–Congo hemorrhagic fever (CCHF) as a high‐priority infectious disease and emphasized the performance of research studies and product development against it. Little information is available about the immune response due to natural CCHF virus (CCHFV) infection in humans. Here, we investigated the persistence of IgG and neutralizing antibodies in serum samples collected from 61 Iranian CCHF survivors with various time points after recovery (60 months after disease). The ELISA results showed IgG seropositivity in all samples while a pseudotyped based neutralization assay findings revealed the presence of neutralizing antibody in 29 samples (46.77%). For both IgG and neutralizing antibodies, a decreasing trend of titer was observed with the increase in the time after recovery. Not only the mean titer of IgG (772.80 U/mL) was higher than mean neutralizing antibody (25.64) but also the IgG persistence was longer. In conclusion, our findings provide valuable information about the long‐term persistence of humoral immune response in CCHF survivors indicating that IgG antibody can be detected at least 8 years after recovery and low titers of neutralizing antibody can be detected in CCHF survivors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemorrhagic Fever, CrimeanHemorrhagic Fever Virus, Crimean-CongoHumansAntibodies, NeutralizingIranImmunoglobulin GAntibodies, Viral

Stichwörter der Autor:innen

Crimean–Congo hemorrhagic feverIgG antibodyarbovirusemerging infectious diseaseneutralizing antibody

Substanzen

Antibodies, NeutralizingImmunoglobulin GAntibodies, Viral

Autor:innen und Institutionen

  • Virology Department, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Arboviruses and Viral Hemorrhagic Fevers (National Reference Laboratory), Pasteur Institute of Iran, Tehran, Iran.
  • Food Microbiology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Research Center for Emerging and Reemerging Infectious Diseases, Pasteur Institute of Iran, Tehran, Iran.

ORCID-Profile: Mostafa Salehi-Vaziri

Förderung

  • Tehran University of Medical Sciences and Health Services

Zitieren

APA

Vasmehjani, A. A., Pouriayevali, M. H., Shahmahmoodi, S., & Salehi-Vaziri, M. (2024). Persistence of IgG and neutralizing antibodies in Crimean−Congo hemorrhagic fever survivors. Journal of Medical Virology. https://doi.org/10.1002/jmv.29581

Vancouver

Vasmehjani AA, Pouriayevali MH, Shahmahmoodi S, Salehi-Vaziri M. Persistence of IgG and neutralizing antibodies in Crimean−Congo hemorrhagic fever survivors. Journal of Medical Virology. 2024. doi:10.1002/jmv.29581

BibTeX
@article{Vasmehjani2024,
  author = {Vasmehjani, Abbas Ahmadi and Pouriayevali, Mohammad Hassan and Shahmahmoodi, Shohreh and Salehi-Vaziri, Mostafa},
  title = {Persistence of IgG and neutralizing antibodies in Crimean−Congo hemorrhagic fever survivors},
  journal = {Journal of Medical Virology},
  year = {2024},
  doi = {10.1002/jmv.29581}
}
Kostenlos starten →